JP2005239680A - Fluorine-containing unsaturated lipid derivative - Google Patents

Fluorine-containing unsaturated lipid derivative Download PDF

Info

Publication number
JP2005239680A
JP2005239680A JP2004054622A JP2004054622A JP2005239680A JP 2005239680 A JP2005239680 A JP 2005239680A JP 2004054622 A JP2004054622 A JP 2004054622A JP 2004054622 A JP2004054622 A JP 2004054622A JP 2005239680 A JP2005239680 A JP 2005239680A
Authority
JP
Japan
Prior art keywords
group
compound
fluorine
added
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004054622A
Other languages
Japanese (ja)
Other versions
JP4437223B2 (en
Inventor
Toshiyuki Takagi
俊之 高木
Katsuki Takai
克毅 高井
Toshiyuki Kanamori
敏幸 金森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST filed Critical National Institute of Advanced Industrial Science and Technology AIST
Priority to JP2004054622A priority Critical patent/JP4437223B2/en
Publication of JP2005239680A publication Critical patent/JP2005239680A/en
Application granted granted Critical
Publication of JP4437223B2 publication Critical patent/JP4437223B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a carbon-carbon unsaturated bond-bearing fluorine-containing alcohol derivative or a new fluorine-containing unsaturated lipid derivative that is linked with one molecule of chiral glycerol and two ester bonds or two ether bonds. <P>SOLUTION: The fluorine-containing lipid derivative is represented by general formula (1) [wherein R<SP>1</SP>through R<SP>4</SP>are each an organic group wherein at least one of R<SP>1</SP>and R3 contains fluorine atom, or the pair of R<SP>1</SP>and R<SP>3</SP>or R<SP>2</SP>and R<SP>4</SP>may be each identical or different; R<SP>5</SP>is H or a metal atom or an organic group or an organic group linking through a P-including group or bearing a group including S; X<SP>1</SP>and X<SP>2</SP>are each C≡C, CH=CH or (CH=CH)<SB>2</SB>, wherein X<SP>1</SP>and X<SP>2</SP>may be identical or different; Y is CO and n is 0 or 1]. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、新規な含フッ素脂質誘導体に関するものである。    The present invention relates to a novel fluorine-containing lipid derivative.

飽和・不飽和脂肪酸などの脂質、グリセロール1分子と2分子の飽和または不飽和脂肪酸によりエステル結合した脂質は界面活性性を有し、採鉱、金属加工、表面仕上げ、及び洗浄用などに使用される各種工業用処理剤、家庭用の各種洗浄剤及び各種清浄剤、医薬品、化粧品や食品用の添加剤などとして広く使用されている。これらの用途の中でも、特に乳化剤、解乳化剤、洗浄剤、分散剤およびヒドロトロープ剤等として有用なものとされている。    Lipids such as saturated and unsaturated fatty acids, and lipids esterified with one and two glycerol saturated or unsaturated fatty acids have surface activity and are used for mining, metalworking, surface finishing, and cleaning. It is widely used as various industrial treatment agents, household cleaning agents and detergents, pharmaceuticals, cosmetics and food additives. Among these uses, they are particularly useful as emulsifiers, demulsifiers, detergents, dispersants, hydrotropes and the like.

従来、この種の不飽和脂肪酸のグリセロールエステルでは、グリセロール1分子と2分子の飽和または不飽和脂肪酸がエステル結合させて、残りの水酸基にリン酸基が結合した非環状のリン脂質化合物が生体内および人為的手段により合成されてきた。これらの物質は、その特性を改善すべく検討が進められている。これらの中で環状の部分を有する場合については、分子剛性の特性が改善されることが考えられ、環状リン脂質の合成が行われている。
また、フッ素原子の導入は、その撥水性を使用した表面改良材として利用されている。さらに炭素−フッ素結合が炭素−水素結合より強固(ブロック効果)であるため、フッ素原子の導入は化合物の安定性を増大させる。フッ素原子は、水素原子とほぼ同じファンデルワールス半径を有する(ミミック効果)ことから構造変化を伴わずに化合物の物性変化をもたらすことができる。
Conventionally, in this type of unsaturated fatty acid glycerol ester, an acyclic phospholipid compound in which one molecule of glycerol and two molecules of saturated or unsaturated fatty acid are ester-bonded and the remaining hydroxyl group is bonded to a phosphate group in vivo. And have been synthesized by human means. These materials are under investigation to improve their properties. Among these, in the case of having a cyclic portion, it is considered that the characteristics of molecular rigidity are improved, and synthesis of cyclic phospholipids is performed.
The introduction of fluorine atoms is used as a surface improvement material using its water repellency. Furthermore, since the carbon-fluorine bond is stronger (block effect) than the carbon-hydrogen bond, introduction of fluorine atoms increases the stability of the compound. Since the fluorine atom has almost the same van der Waals radius as the hydrogen atom (mimic effect), the physical property of the compound can be changed without a structural change.

Vierlingらは、フッ素化したグリセロリン脂質の合成について報告している。グリセロールとフッ素化した不飽和アルコール体およびエステル体とを結合させ、さらに親水基としてホスホコリン基またはホスホエタノールアミン基またはホスホエタノールアミンのポリエチレングリコール(メチルエーテル末端)の導入に成功している。グリセロリン脂質の不飽和は、エーテル体ではエンとジエン、エステル体ではエンのみの合成が報告されている(非特許文献1,2参照)。ところが、これらの化合物はすべてグリセロールの2級水酸基がラセミ体(R体とS体の混合物)であり、キラルなグリセロールのエーテル体およびエステル体を得るには至っていない。さらにジエンのエステル体および三重結合を有するフッ素誘導体の合成は行っていない。   Vierling et al. Report the synthesis of fluorinated glycerophospholipids. Glycerol has been combined with fluorinated unsaturated alcohols and esters, and a phosphocholine group, phosphoethanolamine group, or polyethylene glycol (methyl ether end) of phosphoethanolamine has been successfully introduced as a hydrophilic group. As for the unsaturation of glycerophospholipid, synthesis of only ene and diene in the ether form and only ene in the ester form has been reported (see Non-Patent Documents 1 and 2). However, in these compounds, the secondary hydroxyl group of glycerol is a racemic form (mixture of R and S forms), and chiral ethers and esters of glycerol have not been obtained. Furthermore, synthesis of ester derivatives of diene and fluorine derivatives having a triple bond have not been carried out.

また、Luらは、Rf−C≡C−RとRf−(CH=CH)−Rの合成に成功している。その事例として、RfはCl(CF(n=2,4,8)とCFとC、Rはn−C(n,m=3,7;5,11;6,13;8,17)と(CHOH(n=6,9)を組合せた化合物のみが報告されている(非特許文献3参照)。しかし、Z体の合成および親水性基の導入、グリセロール誘導体の合成は行っていない。 Lu et al. Have succeeded in synthesizing Rf—C≡C—R and Rf— (CH═CH) 2 —R. As an example, Rf is Cl (CF 2 ) n (n = 2, 4, 8), CF 3 and C 2 F 5 , R is n-C n H m (n, m = 3, 7; 5, 11 Only 6,6,13; 8,17) and (CH 2 ) n OH (n = 6, 9) have been reported (see Non-Patent Document 3). However, synthesis of Z-form, introduction of hydrophilic groups, and synthesis of glycerol derivatives are not performed.

また、Prestwichは、一部をフッ素化した(Z)−5−デセニルアセテートを合成し、また三重結合の導入にも成功しているものの、炭素数10個の化合物に限定されており、さらに水酸基には脱保護可能な官能基(アセチル基またはメトキシメチル基またはt−ブチルメチルシリル基)の導入のみである(非特許文献4参照)。E体の合成および親水性基の導入、グリセロール誘導体の合成は行っていない。
Buchananらは、一部をフッ素化した(Z)−11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18−ヘプタデカフルオロ−オクタデカ−8−エノイック酸とそのアルコール体の合成を報告している。その水酸基には脱保護可能なテトラヒドロピラニル基の導入のみが報告されている(非特許文献5参照)。しかし、三重結合体の合成、E体の合成、親水性基の導入、グリセロール誘導体の合成には至っていない。
In addition, Prestwich has synthesized (Z) -5-decenyl acetate partially fluorinated and has succeeded in introducing a triple bond, but is limited to a compound having 10 carbon atoms. Furthermore, only the introduction of a deprotectable functional group (acetyl group, methoxymethyl group or t-butylmethylsilyl group) into the hydroxyl group (see Non-Patent Document 4). Synthesis of E-form, introduction of hydrophilic group, and synthesis of glycerol derivative were not performed.
Buchanan et al. (Z) -11, 11, 12, 12, 13, 13, 14, 14, 15, 15, 16, 16, 17, 17, 18, 18-heptadecafluoro- partially fluorinated The synthesis of octadec-8-enoic acid and its alcohol is reported. Only the introduction of a deprotectable tetrahydropyranyl group has been reported for the hydroxyl group (see Non-Patent Document 5). However, the synthesis of triple bonds, synthesis of E isomers, introduction of hydrophilic groups, and synthesis of glycerol derivatives have not been achieved.

Helvetica Chimica Acta,79,405−425(1996)Helvetica Chimica Acta, 79, 405-425 (1996) J.Fluorine Chem.,107,337−354(2001)J. et al. Fluorine Chem. 107, 337-354 (2001) Tetrahedron,51(43),11765−11774(1995)Tetrahedron, 51 (43), 11765-11774 (1995) J.Org.Chem.,57(1),132−137(1992)J. et al. Org. Chem. , 57 (1), 132-137 (1992) J.Fluorine Chem.,119,207−209(2003)J. et al. Fluorine Chem. , 119, 207-209 (2003)

本発明は、従来の技術における上記した実状に鑑みてなされたものである。すなわち、本発明の目的は、エン(CH=CH)、イン(C≡C)もしくはジエン((CH=CH))という炭素ー炭素不飽和結合を有する含フッ素アルコール誘導体、またはキラルなグリセロール1分子と2個のエステル結合もしくはエーテル結合により結合されて得られる新規な含フッ素不飽和脂質誘導体を提供することにある。 This invention is made | formed in view of the above-mentioned actual condition in a prior art. That is, an object of the present invention is to provide a fluorine-containing alcohol derivative having a carbon-carbon unsaturated bond of ene (CH═CH), in (C≡C) or diene ((CH═CH) 2 ), or chiral glycerol 1 The object is to provide a novel fluorine-containing unsaturated lipid derivative obtained by linking a molecule with two ester bonds or ether bonds.

本発明者らは、前記課題について鋭意研究を重ねた結果、含フッ素不飽和アルコール誘導体を合成できることを見出し、さらに、これらの含フッ素不飽和アルコール誘導体もしくは酸化により得られたカルボン酸またはその誘導体とグリセロールを反応させると、グリセロールが2個のエステルもしくはエーテル結合した新規な含フッ素不飽和脂質誘導体を合成できることを見出した。また、その際、原料物質として、キラルな化合物である示性式HOCHCH(OH)CHOHで示される化合物を用いると、キラルな化合物群を選択的に製造できることを知見し、本発明を完成させるに至った。つまり、本発明では、キラルなグリセロールまたはグリセロールの1位もしくは2位、または1位と2位の水酸基を保護したものを光学分割もしくは酵素を用いた分割により得たもの、または、(S)−(+)−2,2―ジメチル−1,3―ジオキソラン−4−メタノールもしくは(R)−(―)−2,2―ジメチル−1,3―ジオキソラン−4−メタノール、または、(R)−(+)−3―ベンジロキシ−1,2―プロパンジオールもしくは(S)−(−)−3―ベンジロキシ−1,2―プロパンジオールを用いるものである。 As a result of intensive studies on the above problems, the present inventors have found that fluorine-containing unsaturated alcohol derivatives can be synthesized. Further, these fluorine-containing unsaturated alcohol derivatives or carboxylic acids obtained by oxidation or derivatives thereof It has been found that when glycerol is reacted, a novel fluorine-containing unsaturated lipid derivative in which glycerol is linked to two esters or ethers can be synthesized. Further, at that time, it was found that a chiral compound group can be selectively produced by using a compound represented by the sexual formula HOCH 2 CH (OH) CH 2 OH, which is a chiral compound, as a raw material, and the present invention. It came to complete. That is, in the present invention, chiral glycerol or glycerol having a hydroxyl group at the 1-position or 2-position, or the 1-position and 2-position protected is obtained by optical resolution or resolution using an enzyme, or (S)- (+)-2,2-dimethyl-1,3-dioxolane-4-methanol or (R)-(-)-2,2-dimethyl-1,3-dioxolane-4-methanol or (R)- (+)-3-Benzyloxy-1,2-propanediol or (S)-(−)-3-benzyloxy-1,2-propanediol is used.

すなわち、本発明によれば、下記1.〜5.に示す含フッ素脂質誘導体が提供される。
1.一般式(1)

Figure 2005239680
(式中、R〜Rは、それぞれ有機基を示す。RとRは、少なくとも1方がフッ素原子を含む有機基である。またRとR、RとRは、それぞれ同一であっても異なっていても良い。Rは水素原子、金属元素もしくは有機基であるか、またはリン原子を含む基もしくは硫黄原子を含む基を介して結合した有機基を示す。X及びXは、それぞれC≡C、CH=CHまたは(CH=CH)を示す。またXとXは、同一であっても異なっていても良い。Yはカルボニル基を示す。nは0または1である。)で表される含フッ素脂質誘導体。 That is, according to the present invention, the following 1. ~ 5. The fluorine-containing lipid derivative shown in FIG.
1. General formula (1)
Figure 2005239680
(Wherein R 1 to R 4 each represents an organic group. At least one of R 1 and R 3 is an organic group containing a fluorine atom. R 1 and R 3 , R 2 and R 4 are R 5 represents a hydrogen atom, a metal element or an organic group, or an organic group bonded via a group containing a phosphorus atom or a group containing a sulfur atom. X 1 and X 2 each represent C≡C, CH═CH or (CH═CH) 2. X 1 and X 2 may be the same or different, and Y represents a carbonyl group. N is 0 or 1).

2.一般式(2)

Figure 2005239680
(式中、R〜R、X、X及びYは、いずれも前記したと同じ意味である。)で表される含フッ素脂質誘導体。 2. General formula (2)
Figure 2005239680
(Wherein R 1 to R 5 , X 1 , X 2 and Y all have the same meaning as described above).

3.一般式(3)

Figure 2005239680
(式中、R〜R、X、X及びYは、いずれも前記したと同じ意味である。)で表される含フッ素脂質誘導体。 3. General formula (3)
Figure 2005239680
(Wherein R 1 to R 5 , X 1 , X 2 and Y all have the same meaning as described above).

4.一般式(4)

Figure 2005239680
(式中、R〜R、X、X及びYは、いずれも前記したと同じ意味である。)で表される含フッ素脂質誘導体。 4). General formula (4)
Figure 2005239680
(Wherein R 1 to R 5 , X 1 , X 2 and Y all have the same meaning as described above).

5.一般式(5)

Figure 2005239680
(式中、R、R及びXは、いずれも前記したと同じ意味である。ただし、R
及びRは、少なくとも1方がフッ素原子を含む有機基である。Rは親水性の有機基であるか、またはリン原子を含む基もしくは硫黄原子を含む基を介して結合した有機基を示す。)で表される含フッ素脂質誘導体。 5). General formula (5)
Figure 2005239680
(Wherein R 1 , R 2 and X 1 all have the same meaning as described above, provided that R 1
And R 2 is an organic group at least one of which contains a fluorine atom. R 6 represents a hydrophilic organic group or an organic group bonded via a group containing a phosphorus atom or a group containing a sulfur atom. ) -Containing fluorinated lipid derivative.

本発明は、同一分子内に含フッ素有機基とキラルなグリセロールがエステル結合またはエーテル結合した新規化合物を提供するものである。これらの化合物は、界面活性性を有するものであり、産業界および家庭における、例えば、金属加工、採鉱、表面仕上げ、洗浄や清浄、化粧品、医薬、食品加工及び調理などの分野において、殊に乳化剤、解乳化剤、洗浄剤、分散剤あるいはヒドロトロープ剤として用いることができる。   The present invention provides a novel compound in which a fluorine-containing organic group and chiral glycerol are ester-bonded or ether-bonded in the same molecule. These compounds are surface-active and are used as emulsifiers in industry and household, for example in the fields of metalworking, mining, surface finishing, cleaning and cleaning, cosmetics, medicine, food processing and cooking. , Demulsifiers, detergents, dispersants or hydrotropes.

本発明の前記一般式(1)〜(5)で表される含フッ素不飽和脂質誘導体において、まず基R〜Rついて、その内容を具体的に説明する。
基R〜Rは、それぞれ有機基であるが、その中で、RとRは、少なくとも1方がフッ素原子を含む有機基である。またRとR、RとRは、それぞれ同一であっても異なっていても良い。また、基Rは水素原子、金属元素もしくは有機基であるか、またはリン原子を含む基もしくは硫黄原子を含む基を介して結合した有機基である。Rは親水性の有機基であるか、またはリン原子を含む基もしくは硫黄原子を含む基を介して結合した有機基である。その中のリン原子を含む基としては、P、PO、PO、POなどが含まれる。また、硫黄原子を含む基としては、S、SO、SOなどが含まれる。
In the fluorine-containing unsaturated lipid derivative represented by the general formulas (1) to (5) of the present invention, the contents of the groups R 1 to R 6 will be specifically described first.
The groups R 1 to R 4 are each an organic group. Among them, R 1 and R 3 are organic groups in which at least one of them contains a fluorine atom. R 1 and R 3 , R 2 and R 4 may be the same or different. The group R 5 is a hydrogen atom, a metal element or an organic group, or an organic group bonded through a group containing a phosphorus atom or a group containing a sulfur atom. R 6 is a hydrophilic organic group or an organic group bonded through a group containing a phosphorus atom or a group containing a sulfur atom. Among them, the group containing a phosphorus atom includes P, PO, PO 2 , PO 3 and the like. Examples of the group containing a sulfur atom include S, SO, SO 2 and the like.

次に、X及びXは、同一であっても異なっていても良く、それぞれC≡C、CH=CH及び(CH=CH)から選ばれる不飽和炭化水素基である。また、Yはカルボニル基であって、そのカルボニル基の個数を示すnは、0または1である。 X 1 and X 2 may be the same or different and are each an unsaturated hydrocarbon group selected from C≡C, CH═CH and (CH═CH) 2 . Y is a carbonyl group, and n indicating the number of carbonyl groups is 0 or 1.

前記有機基としては、(1)アルキル基、(2)環状アルキル基、(3)アリール基、(4)アラルキル基からなる基から選ばれるものであることが好ましい。また、親水性とは、有機基に水酸基、カルボン酸またはその金属塩(Na、K、Mgなど)、リン酸基、スルホン酸基またはそれらの金属塩(Na、K、Mgなど)などが結合しているものである。
以下、これらの基について、さらに詳細に説明する。
The organic group is preferably selected from the group consisting of (1) an alkyl group, (2) a cyclic alkyl group, (3) an aryl group, and (4) an aralkyl group. In addition, hydrophilicity means that a hydroxyl group, a carboxylic acid or a metal salt thereof (Na, K, Mg, etc.), a phosphate group, a sulfonic acid group or a metal salt thereof (Na, K, Mg, etc.) is bonded to an organic group It is what you are doing.
Hereinafter, these groups will be described in more detail.

(1)アルキル基については以下のとおりである。アルキル基は、直鎖あるいは分岐状アルキル基から選ばれる基である。その炭素数は、通常100個以下、好ましくは72個以下、さらに好ましくは32個以下であり、具体的には、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、sec−ブチル基、t−ブチル基、n−ペンチル基、イソペンチル基、2−メチルブチル基、1−メチルブチル基、n−ヘキシル基、イソヘキシル基、3−メチルペンチル基、2−メチルペンチル基、1−メチルペンチル基、ヘプチル基、オクチル基、イソオクチル基、2−エチルヘキシル基、ノニル基、デシル基、ウンデシル基、ドデシル基、テトラデシル基、ヘキサデシル基、オクタデシル基、エイコシル基等を挙げることができる。
(2)環状アルキル基としては、シクロペンチル基、シクロヘキシル基、アダマンチル基等を挙げることができる。
(3)アリール基としては、フエニル基、ナフタレン基等を挙げることができる。
(4)アラルキル基としては、ベンジル基、フェネチル基等を挙げることができる。
(1) The alkyl group is as follows. The alkyl group is a group selected from linear or branched alkyl groups. The number of carbon atoms is usually 100 or less, preferably 72 or less, more preferably 32 or less. Specifically, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group. Group, sec-butyl group, t-butyl group, n-pentyl group, isopentyl group, 2-methylbutyl group, 1-methylbutyl group, n-hexyl group, isohexyl group, 3-methylpentyl group, 2-methylpentyl group, Examples include 1-methylpentyl group, heptyl group, octyl group, isooctyl group, 2-ethylhexyl group, nonyl group, decyl group, undecyl group, dodecyl group, tetradecyl group, hexadecyl group, octadecyl group, eicosyl group and the like.
(2) Examples of the cyclic alkyl group include a cyclopentyl group, a cyclohexyl group, and an adamantyl group.
(3) Examples of the aryl group include a phenyl group and a naphthalene group.
(4) Examples of the aralkyl group include a benzyl group and a phenethyl group.

前記のアルキル基、環状アルキル基、アリール基又はアラルキル基に置換していても良い置換基としては、本発明の化合物を製造する際に、製造反応に関与しない基であれば差し支えない。置換あるいは未置換アリール基、カルボニル基、アルコキシ基、アルコキシカルボニル基、アシル基、アシルオキシ基、アルキルまたはアリールスルホニル基、ニトロ基、ハロゲン等が例示される。酸素原子、窒素原子、硫黄原子などが結合を介しても良い(ポリエチレングリコールなど)。   The substituent that may be substituted with the alkyl group, cyclic alkyl group, aryl group, or aralkyl group may be any group that does not participate in the production reaction when the compound of the present invention is produced. Examples include substituted or unsubstituted aryl groups, carbonyl groups, alkoxy groups, alkoxycarbonyl groups, acyl groups, acyloxy groups, alkyl or arylsulfonyl groups, nitro groups, halogens, and the like. An oxygen atom, a nitrogen atom, a sulfur atom, or the like may be present through a bond (such as polyethylene glycol).

ハロゲン原子としては、フッ素原子、塩素原子、臭素原子、よう素原子を挙げることができる、有機基に置換した状態であってもよい。金属原子としては、リチウム、ナトリウム、カリウム、ルビジウム、セシウムなどのアルカリ金属、ベリリウム、マグネシウム、カルシウム、ストロンチウム、バリウムなどのアルカリ土類金属、ホウ素、アルミニウム、チタン、錫、鉄などの金属原子を挙げることができる。有機基がこれらを介して含まれていてもよい。   Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. The halogen atom may be substituted with an organic group. Examples of metal atoms include alkali metals such as lithium, sodium, potassium, rubidium and cesium, alkaline earth metals such as beryllium, magnesium, calcium, strontium and barium, and metal atoms such as boron, aluminum, titanium, tin and iron. be able to. An organic group may be contained via these.

上記一般式中のRとRは、前記の(1)〜(4)から選ばれる基を含み、さらにその他に、(5)糖類、(6)アミン類、(7)アミノ酸類、(8)ペプチド類、(9)核酸からなる群から選ばれる基であっても良く、また、リン酸や硫酸などを介して有機基が結合していても良い。 R 5 and R 6 in the above general formula include groups selected from the above (1) to (4), and in addition, (5) saccharides, (6) amines, (7) amino acids, ( 8) Peptides, (9) Groups selected from the group consisting of nucleic acids may be used, and organic groups may be bonded via phosphoric acid or sulfuric acid.

有機基に関して、前記(1)〜(4)以外の基の場合について説明する。
(5)糖類としては特に制限はないが、通常は単糖類、オリゴ糖類である。単糖類としてペントース、ヘキソース、デオキシヘキソース、ヘプトース、アミノ糖が挙げられ、具体的にはアラビノース、リボース、キシロース、グルコース、ガラクトース、マンノース、フルクトース、ラムノース、フコース、ジギトキソース、チマロース、オレアンドロース、ジギタロース、アピオース、ハマメロース、ストレプトース、セドヘプチュロース、コリオース、グルコサミン、ガラクトサミン、2−デオキシ−2−メチルアミノグルコースなどが例示される。オリゴ糖類として非還元性オリゴ糖、還元性オリゴ糖が挙げられ、具体的にはショ糖、トレハロース、ゲンチアノース、ラフィノース、乳糖、セルビオース、麦芽糖、ゲンチオビオースなどが例示される。
Regarding the organic group, the case of a group other than the above (1) to (4) will be described.
(5) Although there is no restriction | limiting in particular as saccharides, Usually, they are a monosaccharide and an oligosaccharide. Examples of monosaccharides include pentose, hexose, deoxyhexose, heptose, and amino sugar. Examples include apiose, hamamelose, streptose, sedoheptulose, coliose, glucosamine, galactosamine, 2-deoxy-2-methylaminoglucose and the like. Examples of oligosaccharides include non-reducing oligosaccharides and reducing oligosaccharides, and specific examples include sucrose, trehalose, gentianose, raffinose, lactose, cerbiose, maltose, and gentiobiose.

(6)アミン類としては、通常含まれる炭素の炭素数50以下、酸素数20以下、窒素数30以下、硫黄数5以下のもの、好ましくは、炭素数35以下、酸素数5以下、窒素数15以下、硫黄数3以下のもの、より好ましくは、炭素数2〜20、酸素数3以下、窒素数2〜10、硫黄数1以下の範囲で構成されるものである。
アミン類としては、ハロゲン原子で置換されていても良く、そのハロゲン原子としてフッ素、塩素、臭素、ヨウ素が挙げられ、1個以上置換されていても良い。また、リン酸基とアミノアルコールが結合しても良い。アミノアルコールとしてコリン、エタノールアミン、セリンが挙げられる。
(6) As amines, the carbon number of carbon normally contained is 50 or less, oxygen number 20 or less, nitrogen number 30 or less, sulfur number 5 or less, preferably carbon number 35 or less, oxygen number 5 or less, nitrogen number It is composed of 15 or less, 3 or less sulfur, more preferably 2 to 20 carbons, 3 or less oxygen, 2 to 10 nitrogens, 1 sulfur or less.
The amines may be substituted with a halogen atom. Examples of the halogen atom include fluorine, chlorine, bromine and iodine, and one or more may be substituted. Moreover, a phosphoric acid group and amino alcohol may couple | bond together. Examples of amino alcohol include choline, ethanolamine, and serine.

(7)アミノ酸類としては、具体的にはグリシン、アラニン、バリン、ロイシン、イソロイシン、セリン、トレオニン、アスパラギン酸、グルタミン酸、アスパラギン、グルタミン、リジン、オルニチン、アルギニン、ヒスチジン、ヒドロキシリジン、システイン、シスチン、メチオニン、フェニルアラニン、チロシン、トリプトファン、プロリン、4−ヒドロキシプロリン、トリコロミン酸、イボテン酸、キスカリン酸、カナバニン、カイニン酸、ドモイ酸、1−アミノシクロプロパンカルボン酸、2−(メチレンシクロプロピル)グリシン、ヒポグリシンA、3−シアノアラニン、アベナ酸、ムギネ酸、ミモシン、レボドパ、β−ヒドロキシ−γ−メチルフルタミン酸、5−ヒドロキシトリプトファン、パントテン酸、ラミニン、ベタシアニンなどが例示される。また、タウリンなどのスルホン酸基を有するアミン類なども挙げられる。 (7) Specific examples of amino acids include glycine, alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, glutamic acid, asparagine, glutamine, lysine, ornithine, arginine, histidine, hydroxylysine, cysteine, cystine, Methionine, phenylalanine, tyrosine, tryptophan, proline, 4-hydroxyproline, tricolomic acid, ibotenic acid, quisqualic acid, canavanine, kainic acid, domoic acid, 1-aminocyclopropanecarboxylic acid, 2- (methylenecyclopropyl) glycine, hypoglycine A, 3-cyanoalanine, avenaic acid, mugineic acid, mimosine, levodopa, β-hydroxy-γ-methylflutamic acid, 5-hydroxytryptophan, pantothenic acid, laminin, betacia Nin and the like are exemplified. Also included are amines having a sulfonic acid group such as taurine.

(8)ペプチド類としては、特に制限されるものではないが、通常含窒素ポリマーであって、2個以上のアミノ酸の重縮合化合物またはタンパク質、ミオグロビン、ヘモグロビンなどのポリペプチドなどが挙げられる。  (8) Peptides are not particularly limited, but are usually nitrogen-containing polymers, and include polycondensation compounds of two or more amino acids or polypeptides such as proteins, myoglobin, hemoglobin, and the like.

(9)核酸としては、ヌクレオシド、ヌクレオチド、もしくはヌクレオチド単位のポリマー鎖が挙げられる。ヌクレオシドは、シトシン、チミン、アデニン、グアニンの塩基と2−デオキシリボースまたはリボースの糖が結合したものが挙げられる。ヌクレオチドは、ヌクレオシドの糖にリン酸基が結合したものが挙げられる。チミンはウラシルでもよい。 (9) Nucleic acids include nucleosides, nucleotides, or polymer chains of nucleotide units. Nucleosides include those in which cytosine, thymine, adenine, guanine base and 2-deoxyribose or ribose sugar are linked. Nucleotides include those in which a phosphate group is bound to a nucleoside sugar. The thymine may be uracil.

また、前記一般式(1)〜(4)で表される化合物の立体配置は、グリセロールの2級水酸基に応じて表現することができる。すなわち、グリセロールの2級水酸基がR配置のものとS配置のものとで示される。   The steric configuration of the compounds represented by the general formulas (1) to (4) can be expressed according to the secondary hydroxyl group of glycerol. That is, the secondary hydroxyl group of glycerol is indicated by the R configuration and the S configuration.

本発明の化合物の製法については、中間体の合成例を含めた実施例などを挙げて具体的に説明するが、本発明はこれらの実施例などによって何ら限定されるものではない。なお、以下に示す化合物番号は、図1〜図3に示すものと同じである。   The production method of the compound of the present invention will be specifically described with reference to examples including synthesis examples of intermediates, but the present invention is not limited to these examples. The compound numbers shown below are the same as those shown in FIGS.

[化合物1の合成]

Figure 2005239680
8−ブロモオクタン−1−オールの無水エーテル溶液に3,4−ジヒドロ−2H−ピラン(1.6当量)とパラトルエンスルホン酸・1水和物(0.1当量)加え、室温で18時間攪拌した。炭酸カリウムを加え、濾過後、減圧下溶媒を留去し、化合物1を得た。(THPは、テトラヒドロピラニル基を示す) [Synthesis of Compound 1]
Figure 2005239680
3,4-Dihydro-2H-pyran (1.6 eq) and paratoluenesulfonic acid monohydrate (0.1 eq) were added to an anhydrous ether solution of 8-bromooctane-1-ol, and 18 hours at room temperature. Stir. Potassium carbonate was added, and after filtration, the solvent was distilled off under reduced pressure to obtain Compound 1. (THP represents a tetrahydropyranyl group)

[化合物2の合成]

Figure 2005239680
氷冷下、リチウムアセチリド・エチレンジアミン(1.1当量)の無水ジメチルスルホキシド懸濁液に化合物1の無水ジメチルスルホキシド溶液を加え、室温で18時間攪拌した。氷水を加え、ヘキサンで抽出後、減圧下溶媒を留去し、減圧蒸留により化合物2を55〜75%で得た。 [Synthesis of Compound 2]
Figure 2005239680
Under ice cooling, an anhydrous dimethyl sulfoxide solution of Compound 1 was added to an anhydrous dimethyl sulfoxide suspension of lithium acetylide · ethylenediamine (1.1 equivalents), and the mixture was stirred at room temperature for 18 hours. After adding ice water and extraction with hexane, the solvent was distilled off under reduced pressure, and Compound 2 was obtained at 55 to 75% by distillation under reduced pressure.

[化合物3の合成]

Figure 2005239680
化合物2のアセトニトリル−水溶液にペルフルオロオクチルヨーダイド(1.2当量)、炭酸水素ナトリウム(0.5当量)、ハイドロサルファナトリウム(0.5当量)を順に加え、室温で4時間撹拌した。水を加えて希釈し、エーテルで抽出後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥した。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(1%酢酸エチル/n−ヘキサン)にて精製し、化合物3を61〜81%で得た。 [Synthesis of Compound 3]
Figure 2005239680
To the acetonitrile-water solution of Compound 2 were added perfluorooctyl iodide (1.2 eq), sodium bicarbonate (0.5 eq), and hydrosulfur sodium (0.5 eq) in this order, and the mixture was stirred at room temperature for 4 hours. The mixture was diluted with water, extracted with ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (1% ethyl acetate / n-hexane) to obtain Compound 3 at 61-81%.

[化合物4の合成]

Figure 2005239680
−20℃のカリウムt−ブトキシド(2.5当量)の無水エーテル溶液に化合物3の無水エーテル溶液を滴下し、−20℃〜0℃で2〜3時間攪拌した。3Mの塩酸水溶液を加え、エーテルで抽出後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(1%酢酸エチル/n−ヘキサン)にて精製し、化合物4を77〜97%で得た。 [Synthesis of Compound 4]
Figure 2005239680
An anhydrous ether solution of compound 3 was added dropwise to an anhydrous ether solution of potassium t-butoxide (2.5 equivalents) at −20 ° C., and the mixture was stirred at −20 ° C. to 0 ° C. for 2 to 3 hours. 3M aqueous hydrochloric acid solution was added, extracted with ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (1% ethyl acetate / n-hexane) to obtain Compound 4 at 77 to 97%.

[化合物5の合成]

Figure 2005239680
氷冷下、化合物4のアセトン溶液にジョーンズ試薬を反応溶液が褐色を保持するまで滴下後、室温で1.5時間攪拌した。2−プロパノールを加え、濾過後、減圧下溶媒を留去した。残査を酢酸エチルで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(15〜25%酢酸エチル/n−ヘキサン)にて精製し、化合物5を72〜92%で得た。 [Synthesis of Compound 5]
Figure 2005239680
Under ice-cooling, Jones reagent was added dropwise to an acetone solution of compound 4 until the reaction solution kept brown, and then stirred at room temperature for 1.5 hours. 2-Propanol was added, and after filtration, the solvent was distilled off under reduced pressure. The residue was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15-25% ethyl acetate / n-hexane) to obtain Compound 5 at 72-92%.

[化合物6の合成]

Figure 2005239680
化合物4のエタノール溶液にp−トルエンスルホン酸ピリジニウム(0.5当量)を加え、55℃で1時間加熱した。冷後、氷水を加え、酢酸エチルで抽出後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、シリカゲルカラムグラフィー(15%酢酸エチル/n−ヘキサン)にて精製し、化合物6を88〜100%で得た。 [Synthesis of Compound 6]
Figure 2005239680
Pyridinium p-toluenesulfonate (0.5 equivalent) was added to the ethanol solution of compound 4 and heated at 55 ° C. for 1 hour. After cooling, ice water was added, extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15% ethyl acetate / n-hexane) to obtain Compound 6 at 88 to 100%.

[化合物7の合成]

Figure 2005239680
化合物6のトルエン溶液に当量の無水酢酸、酢酸、トリフェニルホスフィンと触媒料のビスベンジリデンアセトンパラジウムを順に加え、110℃で15〜18時間加熱した。冷後、濾過し、減圧下溶媒留去後、シリカゲルカラムクロマトグラフィー(5% 酢酸エチル/n−ヘキサン)のより精製し、化合物7を55−75%で得た。(Acは、アセチル基を示す) [Synthesis of Compound 7]
Figure 2005239680
An equivalent amount of acetic anhydride, acetic acid, triphenylphosphine, and bisbenzylideneacetone palladium as a catalyst were sequentially added to a toluene solution of Compound 6 and heated at 110 ° C. for 15 to 18 hours. After cooling, the mixture was filtered and the solvent was distilled off under reduced pressure. The residue was further purified by silica gel column chromatography (5% ethyl acetate / n-hexane) to obtain Compound 7 at 55-75%. (Ac represents an acetyl group)

[化合物8の合成]

Figure 2005239680
化合物7のメタノール溶液に炭酸ナトリウムを加え、室温で18時間攪拌し後、減圧下、溶媒を留去した。水を加えて希釈し、エーテルで抽出後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、シリカゲルカラムクロマトグラフィー(15% 酢酸エチル/n−ヘキサン)にて精製し、化合物8を80−95%で得た。 [Synthesis of Compound 8]
Figure 2005239680
Sodium carbonate was added to the methanol solution of compound 7 and stirred at room temperature for 18 hours, and then the solvent was distilled off under reduced pressure. The mixture was diluted with water, extracted with ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15% ethyl acetate / n-hexane) to obtain Compound 8 at 80-95%.

[化合物9の合成]

Figure 2005239680
氷冷下、化合物8のアセトン溶液にジョーンズ試薬を反応溶液が褐色を保持するまで滴下した後、室温で1.5時間攪拌した。2−プロパノールを加え、濾過後、減圧下溶媒を留去した。残査を酢酸エチルで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー((15〜25% 酢酸エチル/n−ヘキサン)にて精製し、化合物9を70〜90%で得た。 [Synthesis of Compound 9]
Figure 2005239680
Under ice-cooling, Jones reagent was added dropwise to an acetone solution of compound 8 until the reaction solution kept brown, and then stirred at room temperature for 1.5 hours. 2-Propanol was added, and after filtration, the solvent was distilled off under reduced pressure. The residue was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography ((15-25% ethyl acetate / n-hexane) to obtain Compound 9 at 70-90%.

[化合物10a、10bの合成]

Figure 2005239680
化合物3のメタノール溶液にパラトルエンスルホン酸・1水和物(0.1当量)を加え、室温で18時間攪拌し後、減圧下、溶媒を留去した。水を加えて希釈し、エーテルで抽出後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、シリカゲルカラムグラフィー15% 酢酸エチル/n−ヘキサン)にて精製し、化合物10aと10bを88〜100%で得た。 [Synthesis of Compounds 10a and 10b]
Figure 2005239680
Paratoluenesulfonic acid monohydrate (0.1 equivalent) was added to a methanol solution of compound 3, and the mixture was stirred at room temperature for 18 hours, and then the solvent was distilled off under reduced pressure. The mixture was diluted with water, extracted with ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography 15% ethyl acetate / n-hexane) to obtain compounds 10a and 10b at 88 to 100%.

[化合物11aの合成]

Figure 2005239680
−78℃に冷却した化合物10aの無水テトラヒドロフラン溶液に1.6Mのn−ブチルリチウムのヘキサン溶液(4〜5当量)を加えた。1時間後、メタノールを加え、0℃までゆっくりと温度を上昇させた後、飽和塩化アンモニウム水溶液を加え酢酸エチルで抽出し、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥させた。濾過後,減圧下溶媒を留去し、シリカゲルカラムクロマトグラフィー(15% 酢酸エチル/n−ヘキサン)で精製し、化合物11aを71〜91%で得た。 [Synthesis of Compound 11a]
Figure 2005239680
A 1.6 M n-butyllithium hexane solution (4 to 5 equivalents) was added to an anhydrous tetrahydrofuran solution of compound 10a cooled to −78 ° C. After 1 hour, methanol was added and the temperature was slowly raised to 0 ° C., then a saturated aqueous ammonium chloride solution was added, the mixture was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15% ethyl acetate / n-hexane) to obtain compound 11a at 71 to 91%.

[化合物11bの合成]

Figure 2005239680
−78℃に冷却した化合物10bの無水テトラヒドロフラン溶液に1.6Mのn−ブチルリチウムのヘキサン溶液(4〜5当量)を加えた。1時間後、メタノールを加え、0℃までゆっくりと温度を上昇させた後、飽和塩化アンモニウム水溶液を加え酢酸エチルで抽出し、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥させた。濾過後,減圧下溶媒を留去し、シリカゲルカラムクロマトグラフィー(15% 酢酸エチル/n−ヘキサン)で精製し、化合物11bを71〜91%で得た。 [Synthesis of Compound 11b]

Figure 2005239680
A 1.6 M n-butyllithium hexane solution (4 to 5 equivalents) was added to an anhydrous tetrahydrofuran solution of compound 10b cooled to −78 ° C. After 1 hour, methanol was added and the temperature was slowly raised to 0 ° C., then a saturated aqueous ammonium chloride solution was added, the mixture was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15% ethyl acetate / n-hexane) to obtain compound 11b at 71 to 91%.

[化合物12aの合成]

Figure 2005239680
氷冷下、化合物11aのアセトン溶液にジョーンズ試薬を反応溶液が褐色を保持するまで滴下後、室温で1.5時間攪拌した。2−プロパノールを加え、濾過後、減圧下溶媒を留去した。残査を酢酸エチルで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(15〜25% 酢酸エチル/n−ヘキサン)にて精製し、化合物12aを72〜92%で得た。 [Synthesis of Compound 12a]
Figure 2005239680
Under ice-cooling, Jones reagent was added dropwise to an acetone solution of compound 11a until the reaction solution kept brown, and then stirred at room temperature for 1.5 hours. 2-Propanol was added, and after filtration, the solvent was distilled off under reduced pressure. The residue was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15-25% ethyl acetate / n-hexane) to obtain Compound 12a at 72-92%.

[化合物12bの合成]

Figure 2005239680
氷冷下、化合物11bのアセトン溶液にジョーンズ試薬を反応溶液が褐色を保持するまで滴下後、室温で1.5時間攪拌した。2−プロパノールを加え、濾過後、減圧下溶媒を留去した。残査を酢酸エチルで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(15〜25% 酢酸エチル/n−ヘキサン)にて精製し、化合物12bを72〜92%で得た。 [Synthesis of Compound 12b]
Figure 2005239680
Under ice-cooling, Jones reagent was added dropwise to an acetone solution of compound 11b until the reaction solution kept brown, and then stirred at room temperature for 1.5 hours. 2-Propanol was added, and after filtration, the solvent was distilled off under reduced pressure. The residue was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (15-25% ethyl acetate / n-hexane) to obtain Compound 12b at 72-92%.

[化合物13の合成]

Figure 2005239680
氷冷下、2.5当量の2−ブロモエチルジクロロホスフェートのクロロホルム溶液に、2.5当量のトリエチルアミン、化合物6のクロロホルム溶液を滴下し、同温にて4時間撹拌した後、0.1N塩化カリウム水溶液を加え、室温にて1時間攪拌した。クロロホルムで抽出し、減圧下溶媒を留去した後、アセトニトリル:クロロホルム:イソプロパノール=1:1:1混合溶媒と30%トリエチルアミン水溶液を加え、70℃で2時間加熱した。冷後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(65:25:4〜65:35:8=クロロホルム:メタノール:水)にて精製し、化合物13を収率49〜69%で得た。(PCは、ホスホコリン基を示す) [Synthesis of Compound 13]
Figure 2005239680
Under ice cooling, 2.5 equivalents of triethylamine and a chloroform solution of Compound 6 were added dropwise to a solution of 2.5 equivalents of 2-bromoethyldichlorophosphate in chloroform, stirred at the same temperature for 4 hours, and then 0.1N chloride. A potassium aqueous solution was added, and the mixture was stirred at room temperature for 1 hour. After extracting with chloroform and evaporating the solvent under reduced pressure, a mixed solvent of acetonitrile: chloroform: isopropanol = 1: 1: 1 and 30% aqueous triethylamine were added, and the mixture was heated at 70 ° C. for 2 hours. After cooling, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (65: 25: 4-65: 35: 8 = chloroform: methanol: water) to obtain compound 13 in a yield of 49-69. %. (PC represents a phosphocholine group)

化合物13はH−NMRおよび19F−NMRスペクトルにより同定した。その結果は以下の通りである。
H−NMR(TMS、CDCl−CDOD):1.25−1.43(m、8H)、1.53−1.62(m、4H)、2.35(m、2H)、3.29(s、9H)、3.71(bs、2H)、3.84(q、J=6.7Hz、2H)、4.27(bs、2H)。
19F−NMR(CFCl、CDCl−CDOD):−80.71(t、J=10.04Hz、3F)、−96.05(m、2F)、−121.1(m、2F)、−121.8(m、4F)、−122.5〜−122.7(m、4F)、−126.0(m、2F)。
Compound 13 was identified by 1 H-NMR and 19 F-NMR spectra. The results are as follows.
1 H-NMR (TMS, CDCl 3 -CD 3 OD): 1.25-1.43 (m, 8H), 1.53-1.62 (m, 4H), 2.35 (m, 2H), 3.29 (s, 9H), 3.71 (bs, 2H), 3.84 (q, J = 6.7 Hz, 2H), 4.27 (bs, 2H).
19 F-NMR (CFCl 3 , CDCl 3 -CD 3 OD): −80.71 (t, J = 10.04 Hz, 3F), −96.05 (m, 2F), −121.1 (m, 2F) ), -121.8 (m, 4F), -122.5 to -122.7 (m, 4F), -126.0 (m, 2F).

化合物17、18の合成
[化合物14aの合成]

Figure 2005239680
アルゴン雰囲気下、細かく砕いた30当量の水酸化カリウムにジメチルスルホキシドを加え、懸濁状とした。水冷下、(S)−(+)−2,2−ジメチル−1,3−ジオキソラン−4−メタノールのジメチルスルホキシド溶液を滴下した。次に3.5当量のベンジルブロミドを滴下した。室温で3時間撹拌させた後、氷水を加えて反応を止め、酢酸エチルで抽出し、氷水、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(5% 酢酸エチル/n−ヘキサン)に通して精製して得られた化合物に10%酢酸水溶液を加え、90度で3時間加熱した。冷後、酢酸エチルで抽出し、水、飽和炭酸水素ナトリウム水溶液、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(80〜100% 酢酸エチル/n−ヘキサン)に通して精製し、化合物14aを70〜90%で得た。 Synthesis of Compounds 17 and 18 [Synthesis of Compound 14a]
Figure 2005239680
Under an argon atmosphere, dimethyl sulfoxide was added to 30 equivalents of finely pulverized potassium hydroxide to form a suspension. Under water cooling, a dimethyl sulfoxide solution of (S)-(+)-2,2-dimethyl-1,3-dioxolane-4-methanol was added dropwise. Next, 3.5 equivalents of benzyl bromide were added dropwise. After stirring at room temperature for 3 hours, the reaction was stopped by adding ice water, extracted with ethyl acetate, washed with ice water and saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (5% ethyl acetate / n-hexane). A 10% acetic acid aqueous solution was added to the compound obtained by adding 3% at 90 ° C. Heated for hours. After cooling, the mixture was extracted with ethyl acetate, washed with water, saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (80 to 100% ethyl acetate / n-hexane) to obtain Compound 14a at 70 to 90%.

[化合物14bの合成]

Figure 2005239680
アルゴン雰囲気下、細かく砕いた30当量の水酸化カリウムにジメチルスルホキシドを加え、懸濁状とした。水冷下、(R)−(+)−2,2−ジメチル−1,3−ジオキソラン−4−メタノールのジメチルスルホキシド溶液を滴下した。次に3.5当量のベンジルブロミドを滴下した。室温で3時間撹拌させた後、氷水を加えて反応を止め、酢酸エチルで抽出し、氷水、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(5% 酢酸エチル/n−ヘキサン)に通して精製して得られた化合物に10%酢酸水溶液を加え、90度で3時間加熱した。冷後、酢酸エチルで抽出し、水、飽和炭酸水素ナトリウム水溶液、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(80〜100% 酢酸エチル/n−ヘキサン)に通して精製し、化合物14bを70〜90%で得た。 [Synthesis of Compound 14b]
Figure 2005239680
Under an argon atmosphere, dimethyl sulfoxide was added to 30 equivalents of finely pulverized potassium hydroxide to form a suspension. Under water cooling, a dimethyl sulfoxide solution of (R)-(+)-2,2-dimethyl-1,3-dioxolane-4-methanol was added dropwise. Next, 3.5 equivalents of benzyl bromide were added dropwise. After stirring at room temperature for 3 hours, the reaction was stopped by adding ice water, extracted with ethyl acetate, washed with ice water and saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (5% ethyl acetate / n-hexane). A 10% acetic acid aqueous solution was added to the compound obtained by adding 3% at 90 ° C. Heated for hours. After cooling, the mixture was extracted with ethyl acetate, washed with water, saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (80 to 100% ethyl acetate / n-hexane) to obtain Compound 14b at 70 to 90%.

[化合物15の合成]

Figure 2005239680
氷冷下、化合物6の無水塩化メチレン溶液にトリエチルアミン(2当量)、メタンスルホニルクロリド(1当量)を加えた。1〜2時間攪拌後、氷水を加え、塩化メチレンで抽出し、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(30% 酢酸エチル/n−ヘキサン)に通して精製し、化合物14bを70〜90%で得た。(Msは、メタンスルホニル基を示す) [Synthesis of Compound 15]
Figure 2005239680
Under ice-cooling, triethylamine (2 equivalents) and methanesulfonyl chloride (1 equivalent) were added to an anhydrous methylene chloride solution of Compound 6. After stirring for 1-2 hours, ice water was added, extracted with methylene chloride, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (30% ethyl acetate / n-hexane) to obtain Compound 14b at 70 to 90%. (Ms represents a methanesulfonyl group)

[化合物16の合成]

Figure 2005239680
水素化ナトリウムの無水テトラヒドロフラン溶液に化合物14aを加え、室温で4時間攪拌し、さらに65℃で1時間加熱した。そこに化合物15の無水テトラヒドロフラン溶液に化合物を加え、3日間加熱還流した。冷後、氷水を加え、エーテルで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(10% 酢酸エチル/n−ヘキサン) に通して精製し、化合物16を58−78%で得た。 [Synthesis of Compound 16]
Figure 2005239680
Compound 14a was added to an anhydrous tetrahydrofuran solution of sodium hydride, stirred at room temperature for 4 hours, and further heated at 65 ° C. for 1 hour. The compound was added to the anhydrous tetrahydrofuran solution of the compound 15 there, and it heated and refluxed for 3 days. After cooling, ice water was added, extracted with ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (10% ethyl acetate / n-hexane) to obtain Compound 16 at 58-78%.

化合物16はH−NMRおよび19F−NMRスペクトルにより同定した。その結果は以下の通りである。
H−NMR(CDCl,TMS):7.23(d、J=8.5Hz、2H)、6.87(d、J=8.5Hz、2H)、4.46(s、2H)、3.79(s、3H)、3.39−3.60(m、9H)、2.35(m、4H)、1.54−1.64(m、8H)、1.28−1.47(m、16H)。
19F−NMR(CDCl、CFCl):−80.64(t、J=9.71Hz、6F)、−95.58(m、4F)、−120.49(m、4F)、−121.88(m、8F)、−122.55〜−122.74(m、8F)、−126.03(m、4F)。
Compound 16 was identified by 1 H-NMR and 19 F-NMR spectra. The results are as follows.
1 H-NMR (CDCl 3 , TMS): 7.23 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 4.46 (s, 2H), 3.79 (s, 3H), 3.39-3.60 (m, 9H), 2.35 (m, 4H), 1.54-1.64 (m, 8H), 1.28-1. 47 (m, 16H).
19 F-NMR (CDCl 3 , CFCl 3 ): −80.64 (t, J = 9.71 Hz, 6F), −95.58 (m, 4F), −120.49 (m, 4F), −121 .88 (m, 8F), −122.55 to −122.74 (m, 8F), −126.03 (m, 4F).

[化合物17の合成]

Figure 2005239680
氷冷下、化合物16の塩化メチレン溶液にリン酸緩衝液(pH7.0)を加えた後、少量の2,3−ジクロロ−5,6−ジシアノ−1,4−ベンゾキノンを加え、8時間攪拌した。飽和炭酸水素ナトリウム水溶液を加え、濾過後、塩化メチレンで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(30% 酢酸エチル/n−ヘキサン) に通して精製し、化合物17を58−78%で得た。 [Synthesis of Compound 17]
Figure 2005239680
A phosphate buffer solution (pH 7.0) was added to a methylene chloride solution of Compound 16 under ice cooling, and then a small amount of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone was added and stirred for 8 hours. did. Saturated aqueous sodium hydrogen carbonate solution was added, filtered, extracted with methylene chloride, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (30% ethyl acetate / n-hexane) to obtain Compound 17 at 58-78%.

化合物17はH−NMRおよび19F−NMRスペクトルにより同定した。その結果は以下の通りである。
H−NMR(CDCl,TMS):3.39−3.60(m、9H)、2.35(m、4H)、2.17(bs、2H)、1.54−1.64(m、8H)、1.28−1.47(m、16H)。
19F−NMR(CDCl、CFCl):−80.64(t、J=9.71Hz、6F)、−95.58(m、4F)、−120.49(m、4F)、−121.88(m、8F)、−122.55〜−122.74(m、8F)、−126.03(m、4F)。
Compound 17 was identified by 1 H-NMR and 19 F-NMR spectra. The results are as follows.
1 H-NMR (CDCl 3 , TMS): 3.39-3.60 (m, 9H), 2.35 (m, 4H), 2.17 (bs, 2H), 1.54-1.64 ( m, 8H), 1.28-1.47 (m, 16H).
19 F-NMR (CDCl 3 , CFCl 3 ): −80.64 (t, J = 9.71 Hz, 6F), −95.58 (m, 4F), −120.49 (m, 4F), −121 .88 (m, 8F), −122.55 to −122.74 (m, 8F), −126.03 (m, 4F).

[化合物18の合成]

Figure 2005239680
氷冷下、2.5当量の2−ブロモエチルジクロロホスフェートのクロロホルム溶液に、2.5当量のトリエチルアミン、化合物17のクロロホルム溶液を滴下し、同温にて4時間撹拌した後、0.1N塩化カリウム水溶液を加え、室温にて1時間攪拌した。クロロホルムで抽出し、減圧下溶媒を留去した後、アセトニトリル:クロロホルム:イソプロパノール=1:1:1混合溶媒と30%トリエチルアミン水溶液を加え、70℃で2時間加熱した。冷後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(65:25:4〜65:35:8=クロロホルム:メタノール:水)にて精製し、化合物18を49−69%で得た。 [Synthesis of Compound 18]
Figure 2005239680
Under ice-cooling, 2.5 equivalents of a solution of 2-bromoethyldichlorophosphate in chloroform was added dropwise with 2.5 equivalents of a solution of triethylamine and compound 17 in chloroform, and the mixture was stirred at the same temperature for 4 hours. A potassium aqueous solution was added, and the mixture was stirred at room temperature for 1 hour. After extracting with chloroform and evaporating the solvent under reduced pressure, a mixed solvent of acetonitrile: chloroform: isopropanol = 1: 1: 1 and 30% aqueous triethylamine were added, and the mixture was heated at 70 ° C. for 2 hours. After cooling, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (65: 25: 4-65: 35: 8 = chloroform: methanol: water) to obtain compound 18 at 49-69%. Obtained.

化合物18はH−NMRおよび19F−NMRスペクトルにより同定した。その結果は以下の通りである。
H−NMR(CDCl,TMS):4.00−4.21(m、2H)、3.78(bs、2H)、3.25−3.65(m、9H)、3.09(s、9H)、2.35(m、4H)、1.54−1.64(m、8H)、1.28−1.47(m、16H)。
19F−NMR(CDCl、CFCl):−80.64(t、J=9.71Hz、6F)、−95.58(m、4F)、−120.49(m、4F)、−121.88(m、8F)、−122.55〜−122.74(m、8F)、−126.03(m、4F)。
Compound 18 was identified by 1 H-NMR and 19 F-NMR spectra. The results are as follows.
1 H-NMR (CDCl 3 , TMS): 4.00-4.21 (m, 2H), 3.78 (bs, 2H), 3.25-3.65 (m, 9H), 3.09 ( s, 9H), 2.35 (m, 4H), 1.54-1.64 (m, 8H), 1.28-1.47 (m, 16H).
19 F-NMR (CDCl 3 , CFCl 3 ): −80.64 (t, J = 9.71 Hz, 6F), −95.58 (m, 4F), −120.49 (m, 4F), −121 .88 (m, 8F), −122.55 to −122.74 (m, 8F), −126.03 (m, 4F).

化合物20、21の合成
[化合物19の合成]

Figure 2005239680
化合物12aと化合物14bのジメチルホルムアミド溶液に1.2当量の4−ジメチルアミノピリジンおよび1,3−ジシクロヘキシルカルボジイミドを加え、室温で24時間攪拌した。氷水を加えて反応を止め、塩化メチレンで抽出し、冷10%塩酸水溶液、飽和炭酸水素ナトリウム水溶液、飽和食塩水で順次洗浄し、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(15%酢酸エチル/ヘキサン)に通して精製し、化合物19を得た。 Synthesis of Compounds 20 and 21 [Synthesis of Compound 19]
Figure 2005239680
1.2 equivalents of 4-dimethylaminopyridine and 1,3-dicyclohexylcarbodiimide were added to a dimethylformamide solution of compound 12a and compound 14b, and the mixture was stirred at room temperature for 24 hours. Ice water was added to stop the reaction, and the mixture was extracted with methylene chloride, washed sequentially with a cold 10% aqueous hydrochloric acid solution, a saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (15% ethyl acetate / hexane) to obtain Compound 19.

[化合物20の合成]


Figure 2005239680
氷冷下、化合物19の塩化メチレン溶液にリン酸緩衝液(pH7.0)を加えた後、少量の2,3−ジクロロ−5,6−ジシアノ−1,4−ベンゾキノンを加え、8時間攪拌した。飽和炭酸水素ナトリウム水溶液を加え、濾過後、塩化メチレンで抽出し、飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥させた。濾過後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(30%酢酸エチル/n−ヘキサン) に通して精製し、化合物20を得た。 [Synthesis of Compound 20]


Figure 2005239680
A phosphate buffer solution (pH 7.0) was added to a methylene chloride solution of compound 19 under ice cooling, a small amount of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone was added, and the mixture was stirred for 8 hours. did. Saturated aqueous sodium hydrogen carbonate solution was added, filtered, extracted with methylene chloride, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by passing through silica gel column chromatography (30% ethyl acetate / n-hexane) to obtain Compound 20.

[化合物21の合成]

Figure 2005239680
氷冷下、2.5当量の2−ブロモエチルジクロロホスフェートのクロロホルム溶液に、2.5当量のトリエチルアミン、化合物20のクロロホルム溶液を滴下し、同温にて4時間撹拌した後、0.1N塩化カリウム水溶液を加え、室温にて1時間攪拌した。クロロホルムで抽出し、減圧下溶媒を留去した後、アセトニトリル:クロロホルム:イソプロパノール=1:1:1混合溶媒と30%トリエチルアミン水溶液を加え、70℃で2時間加熱した。冷後、減圧下溶媒を留去し、残査をシリカゲルカラムクロマトグラフィー(65:25:4〜65:35:8=クロロホルム:メタノール:水)にて精製し、化合物21を得た。 [Synthesis of Compound 21]
Figure 2005239680
Under ice-cooling, 2.5 equivalent of triethylamine and a chloroform solution of compound 20 were added dropwise to 2.5 equivalent of 2-bromoethyldichlorophosphate in chloroform, and the mixture was stirred at the same temperature for 4 hours. A potassium aqueous solution was added, and the mixture was stirred at room temperature for 1 hour. After extracting with chloroform and evaporating the solvent under reduced pressure, a mixed solvent of acetonitrile: chloroform: isopropanol = 1: 1: 1 and 30% aqueous triethylamine were added, and the mixture was heated at 70 ° C. for 2 hours. After cooling, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (65: 25: 4 to 65: 35: 8 = chloroform: methanol: water) to obtain Compound 21.

本発明の含フッ素脂質誘導体は、同一分子内に含フッ素有機基とエステル結合またはエーテル結合を持つ新規な化合物であって、界面活性性を有することから、広範な技術分野に用いられる界面活性剤などとして利用できるものである。   The fluorine-containing lipid derivative of the present invention is a novel compound having a fluorine-containing organic group and an ester bond or an ether bond in the same molecule, and has a surfactant, so that it is a surfactant used in a wide range of technical fields. It can be used as such.

本発明における含フッ素脂質誘導体の合成中間体の一例の合成経路を示す化学反応式である。2 is a chemical reaction formula showing a synthetic route of an example of a synthetic intermediate of a fluorinated lipid derivative in the present invention. 本発明における含フッ素脂質誘導体の一例の合成経路を示す化学反応式である。2 is a chemical reaction formula showing a synthesis route of an example of a fluorinated lipid derivative in the present invention. 本発明における他の含フッ素脂質誘導体の一例の合成経路を示す化学反応式である。2 is a chemical reaction formula showing a synthetic route of an example of another fluorine-containing lipid derivative in the present invention.

Claims (5)

下記一般式(1)
Figure 2005239680
(式中、R〜Rは、それぞれ有機基を示す。RとRは、少なくとも1方がフッ素原子を含む有機基である。またRとR、RとRは、それぞれ同一であっても異なっていても良い。Rは水素原子、金属元素もしくは有機基であるか、またはリン原子を含む基もしくは硫黄原子を含む基を介して結合した有機基を示す。X及びXは、それぞれC≡C、CH=CHまたは(CH=CH)を示す。またXとXは、同一であっても異なっていても良い。Yはカルボニル基を示す。nは0または1である。)で表される含フッ素脂質誘導体。
The following general formula (1)
Figure 2005239680
(Wherein R 1 to R 4 each represents an organic group. At least one of R 1 and R 3 is an organic group containing a fluorine atom. R 1 and R 3 , R 2 and R 4 are R 5 represents a hydrogen atom, a metal element or an organic group, or an organic group bonded via a group containing a phosphorus atom or a group containing a sulfur atom. X 1 and X 2 each represent C≡C, CH═CH or (CH═CH) 2. X 1 and X 2 may be the same or different, and Y represents a carbonyl group. N is 0 or 1).
下記一般式(2)
Figure 2005239680
(式中、R〜R、X、X及びYは、いずれも前記したと同じ意味である。)で表される含フッ素脂質誘導体。
The following general formula (2)
Figure 2005239680
(Wherein R 1 to R 5 , X 1 , X 2 and Y all have the same meaning as described above).
下記一般式(3)
Figure 2005239680
(式中、R〜R、X、X及びYは、いずれも前記したと同じ意味である。)で表される含フッ素脂質誘導体。

The following general formula (3)
Figure 2005239680
(Wherein R 1 to R 5 , X 1 , X 2 and Y all have the same meaning as described above).

下記一般式(4)
Figure 2005239680
(式中、R〜R、X、X及びYは、いずれも前記したと同じ意味である。)で表される含フッ素脂質誘導体。
The following general formula (4)
Figure 2005239680
(Wherein R 1 to R 5 , X 1 , X 2 and Y all have the same meaning as described above).
下記一般式(5)
Figure 2005239680
(式中、R、R及びXは、いずれも前記したと同じ意味である。ただし、R
は、少なくとも1個のフッ素原子を含む有機基である。Rは親水性の有機基であるか、またはリン原子を含む基もしくは硫黄原子を含む基を介して結合した有機基を示す。)で表される含フッ素脂質誘導体。

The following general formula (5)
Figure 2005239680
(Wherein R 1 , R 2 and X 1 all have the same meaning as described above, provided that R 1
Is an organic group containing at least one fluorine atom. R 6 represents a hydrophilic organic group or an organic group bonded via a group containing a phosphorus atom or a group containing a sulfur atom. ) -Containing fluorinated lipid derivative.

JP2004054622A 2004-02-27 2004-02-27 Fluorine-containing unsaturated lipid derivatives Expired - Lifetime JP4437223B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004054622A JP4437223B2 (en) 2004-02-27 2004-02-27 Fluorine-containing unsaturated lipid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004054622A JP4437223B2 (en) 2004-02-27 2004-02-27 Fluorine-containing unsaturated lipid derivatives

Publications (2)

Publication Number Publication Date
JP2005239680A true JP2005239680A (en) 2005-09-08
JP4437223B2 JP4437223B2 (en) 2010-03-24

Family

ID=35021785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004054622A Expired - Lifetime JP4437223B2 (en) 2004-02-27 2004-02-27 Fluorine-containing unsaturated lipid derivatives

Country Status (1)

Country Link
JP (1) JP4437223B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009007460A (en) * 2007-06-27 2009-01-15 Nippon Polyurethane Ind Co Ltd Organic polyisocyanate composition, and coating composition and adhesive composition using the same
WO2012014818A1 (en) * 2010-07-30 2012-02-02 日本ゼオン株式会社 Ether compound, electrolyte composition for non-aqueous battery, binder composition for non-aqueous battery electrode, slurry composition for non-aqueous battery electrode, electrode for non-aqueous battery and non-aqueous battery
JP2015172011A (en) * 2014-03-11 2015-10-01 国立研究開発法人産業技術総合研究所 Pseudo-cyclic lipid compound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009007460A (en) * 2007-06-27 2009-01-15 Nippon Polyurethane Ind Co Ltd Organic polyisocyanate composition, and coating composition and adhesive composition using the same
WO2012014818A1 (en) * 2010-07-30 2012-02-02 日本ゼオン株式会社 Ether compound, electrolyte composition for non-aqueous battery, binder composition for non-aqueous battery electrode, slurry composition for non-aqueous battery electrode, electrode for non-aqueous battery and non-aqueous battery
CN103038224A (en) * 2010-07-30 2013-04-10 日本瑞翁株式会社 Ether compound, electrolyte composition for non-aqueous battery, binder composition for non-aqueous battery electrode, slurry composition for non-aqueous battery electrode, electrode for non-aqueous battery and non-aqueous battery
JPWO2012014818A1 (en) * 2010-07-30 2013-09-12 日本ゼオン株式会社 Ether compound, non-aqueous battery electrolyte composition, non-aqueous battery electrode binder composition, non-aqueous battery electrode slurry composition, non-aqueous battery electrode and non-aqueous battery
JP2015172011A (en) * 2014-03-11 2015-10-01 国立研究開発法人産業技術総合研究所 Pseudo-cyclic lipid compound

Also Published As

Publication number Publication date
JP4437223B2 (en) 2010-03-24

Similar Documents

Publication Publication Date Title
Zhou et al. Geminal difunctionalization of α-diazo arylmethylphosphonates: synthesis of fluorinated phosphonates
JP2005089441A (en) Manufacturing method of highly stereoregular phosphorus atom-modified nucleotide analogue
WO2008001718A1 (en) Dehydroxylated fluorinating agent
JP2011088935A (en) Optically-active nucleoside 3&#39;-phosphoroamidite for production of phosphorus atom modified nucleotide analog
JP5044965B2 (en) Method for producing α-glycerophosphorylcholine crystals
Imaizumi et al. Highly Potent Chiral Labeling Reagents for the Discrimination of Chiral Alcohols∗
JP2008001704A (en) Process for producing glycerol carbonate ester
JP2005239680A (en) Fluorine-containing unsaturated lipid derivative
EP2513121A1 (en) Prostate specific membrane antigen inhibitors
Carballeira et al. Facile syntheses for (5Z, 9Z)-5, 9-hexadecadienoic acid,(5Z, 9Z)-5, 9-nonadecadienoic acid, and (5Z, 9Z)-5, 9-eicosadienoic acid through a common synthetic route
JP2004075586A (en) Cyclic ester compound
Jiang et al. CuX2-mediated halocyclization of 1, 1-difluoro-2, 3-allenylphosphonic acid monoesters–synthesis of novel cyclic phosphate mimics
US7777066B2 (en) Glycero-compound having triple bond and membrane material containing the same
JP4210744B2 (en) Sphingolipid derivatives
KR20090007558A (en) Method and process for preparing cardiolipin
JP2003286281A (en) Cyclic ether compound
Marhold et al. Synthesis of optically active 2-fluoroalk-1-en-3-yl esters and chirality transfer in their Claisen-type rearrangements
Yuan et al. A facial chemoenzymatic method for the preparation of chiral 1, 2-dihydroxy-3, 3, 3,-trifluoropropanephosphonates
JP4300293B2 (en) Fluorine-containing unsaturated thiol derivative
Stamatov et al. O-Silylated C3-halohydrins as a novel class of protected building blocks for total, regio-and stereocontrolled synthesis of glycerolipid frameworks
JP2004002215A (en) Method for producing sphingolipid derivative
JP4189485B2 (en) Cyclic amide compound
JP6341479B2 (en) Pseudocyclic lipid compounds
JP4446063B2 (en) Fluorine-containing polyacetylene derivative
KR100744834B1 (en) Method for preparing of fluorinated alkoxysilane derivatives

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091208

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

R150 Certificate of patent or registration of utility model

Ref document number: 4437223

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term